Protect and repair

Discovering new ways to protect and repair the brain

When the brain is affected by an injury, a disease or disorder, it can change a person’s life drastically.

The Florey’s researchers in the Protect and Repair mission are renowned experts in a diverse range of brain conditions, united by their commitment to further our understanding of neurodegenerative diseases and brain injuries to improve care and develop new treatments, including the innovative use of stem cells to repair the brain.

The challenge

Key people

Conditions covered in Protect and repair

Research groups

Autonomic Neuroscience Group

The Autonomic Neuroscience Group investigates the groups of brain cells responsible for controlling bodily functions like heart rate and temperature regulation.
Learn more
AVERT Early Rehabilitation Research Group

The AVERT group works to develop the most effective treatments and environments to maximise recovery in people after stroke.
Learn more
Digestive Physiology and Nutrition Group

The Digestive Physiology and Nutrition Group researches digestive physiology and nutrition, including inflammatory bowel disease.
Learn more
Motor Neurone Disease Group

Neurodegenerative diseases have a devastating impact on quality of life and impose a tremendous burden on the health care system. Among neurodegenerative conditions, motor neurodegenerative diseases are the among the most rapidly fatal, with increasing disability and death within 2-3 years from symptom onset.
Learn more
Multiple Sclerosis and Myelin Repair Group

We are multi-disciplinary group straddling the fields of immunology, genetics and myelin biology, with a particular interest in the intersection of these disciplines in MS susceptibility, severity and recovery.
Learn more
Myelin in Health and Disease Group

We study myelin's role in motor neuron disease and development using iPSCs and organoids, and investigate myelin in other diseases.
Learn more
Neurocardiovascular Physiology Group

Exploring brain communication with vital organs in disease we utilise advanced techniques to improve outcomes in heart failure, infection and inflammation.
Learn more
Neuroepidemiology Group

Within the institute, the Early Brain division focuses on understanding the neurodevelopment, neuroregeneration and networks of developing brain. The emphasis is also on disease prevention and understating triggers for disease onset such as environment, genetics and epigenetics.
Learn more
Neurogenetics Group

We aim to characterise the role of genes in human brain diseases with a view to improving biological and mechanistic understanding, thus facilitating the development of better therapies.
Learn more
Neuroinflammation Group

Neurodegenerative diseases affect cells in the brain, called neurons. Over time, these cells deteriorate and die. Associated with this death is an abnormal build-up of proteins such as tau or TDP-43. Most of these diseases, including dementias and motor neurone disease, have no cure and few effective treatments.
Learn more
Neurorehabilitation and Recovery Group

We are a multidisciplinary team of researchers, health professionals and research students committed to improving quality of life for survivors of stroke.
Learn more
Neurotherapeutics Group

This research team has expertise in Medicinal Chemistry (in association with Prana Biotechnology) and in biomarker discovery. More recently, it has focussed on the pathways leading to Parkinson’s disease, especially around the oxidative modifications of tau.
Learn more
Parkinson’s Disease Group

Our aim is to find a cure for Parkinson’s and improve patients’ lives with support from patients, caregivers, researchers and biotech companies.
Learn more
Peptide and Oligonucleotide Therapeutics Group

The focus of our research is to exploit antisense technology for the development of therapeutics for neurodegenerative diseases.
Learn more
Personalised Therapeutics Group

We use stem cells and genomics technologies to model neurodegenerative diseases such as motor neurone disease, Parkinson’s disease and dementia.
Learn more
Pre-clinical Critical Care Group

Our laboratory is focused on understanding how genetic, neurochemical and structural changes that occur in the brain following myocardial infarction contributes to an overactive sympathetic nervous system and consequently disease progression into heart failure.
Learn more
Public Health and Health Services Research Group

The Australian Stroke Clinical Registry undertakes research to improve the delivery of evidence-based care and achieve better health outcomes after stroke.
Learn more
Sleep and Cognition Group

Our lab focuses on the role of sleep in memory, mood, emotion and neurodegenerative disease.
Learn more
Stem Cells and Neural Development Group

Our focus is using human stem cells to model neurological diseases, develop therapies and understand human neural development for regeneration.
Learn more
Translational Cardiovascular and Renal Research Group

Our group aims to offer solutions to health complications such as brain and kidney injury that can arise from sepsis and heart surgery.
Learn more
Translational Neurodegeneration Group

The goal of our group is to discover and translate new drugs and biomarkers for patients with neurodegenerative diseases, specifically dementia. We conduct research across the translational spectrum, including cell culture, animal physiology, fluid and imaging biomarkers, and clinical trials, to better understand disease mechanisms and identify therapeutic targets. Our areas of focus include cell death…
Learn more